carbon monoxide has been researched along with Mood Disorders in 3 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results from this study will inform FDA on the potential effects of regulating the nicotine content of cigarettes and help determine whether smokers with mood and/or anxiety disorders can safely transition to significantly reduced nicotine content cigarettes." | 9.24 | A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. ( Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J, 2017) |
| "Results from this study will inform FDA on the potential effects of regulating the nicotine content of cigarettes and help determine whether smokers with mood and/or anxiety disorders can safely transition to significantly reduced nicotine content cigarettes." | 5.24 | A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. ( Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Minami, H | 1 |
| Nahvi, S | 1 |
| Arnsten, JH | 1 |
| Brinkman, HR | 1 |
| Rivera-Mindt, M | 1 |
| Wetter, DW | 1 |
| Bloom, EL | 1 |
| Price, LH | 1 |
| Richman, EK | 1 |
| Betzler, TF | 1 |
| Stockmal, C | 1 |
| Donnelly, R | 1 |
| McClain, LM | 1 |
| Kennedy, KA | 1 |
| Vieira, C | 1 |
| Fine, M | 1 |
| McCarthy, DE | 1 |
| Thomas, JG | 1 |
| Hecht, J | 1 |
| Brown, RA | 1 |
| Brunette, MF | 1 |
| Ferron, JC | 1 |
| Drake, RE | 1 |
| Devitt, TS | 1 |
| Geiger, PT | 1 |
| McHugo, GJ | 1 |
| Jonikas, JA | 1 |
| Cook, JA | 1 |
| Allen, SI | 1 |
| Foulds, J | 1 |
| Pachas, GN | 1 |
| Veldheer, S | 1 |
| Cather, C | 1 |
| Azzouz, N | 1 |
| Hrabovsky, S | 1 |
| Hameed, A | 1 |
| Yingst, J | 1 |
| Hammett, E | 1 |
| Modesto, J | 1 |
| Krebs, NM | 1 |
| Zhu, J | 1 |
| Liao, J | 1 |
| Muscat, JE | 1 |
| Richie, J | 1 |
| Evins, AE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Brief Mindfulness Cessation Training With EMA for Post-hospital Depressed Smokers[NCT02742610] | 60 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders[NCT01928758] | 245 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Smokers assigned to reduced nicotine content cigarettes will be more likely to successfully abstain from smoking at the end of the trial, based on all randomized participants, defined as no cigarette use in past 7 days, verified by exhaled carbon monoxide <10ppm. (NCT01928758)
Timeframe: Follow-up appointment 30 weeks after randomization (12 weeks after last visit of randomized trial phase).
| Intervention | Participants (Count of Participants) |
|---|---|
| Reduced Nicotine Content Cigarettes | 17 |
| Usual Nicotine Content Cigarettes | 4 |
Smokers assigned to the reduced nicotine content cigarette group may have lower perceived dependence and be more likely to report intention to quit smoking (NCT01928758)
Timeframe: At end of 18-week randomized trial phase
| Intervention | Participants (Count of Participants) |
|---|---|
| Reduced Nicotine Content Cigarettes | 33 |
| Usual Nicotine Content Cigarettes | 25 |
This 8-item scale measures nicotine withdrawal symptoms and the scale range is from 0-32. Higher scores indicate higher severity. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
| Intervention | score on a scale (Mean) |
|---|---|
| Reduced Nicotine Content Cigarettes | 8.1 |
| Usual Nicotine Content Cigarettes | 9.0 |
10-item questionnaire measuring the degree to which life situations are appraised stressful. Scale range is 0-40. Higher scores indicate more stress. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
| Intervention | score on a scale (Mean) |
|---|---|
| Reduced Nicotine Content Cigarettes | 15.0 |
| Usual Nicotine Content Cigarettes | 15.1 |
Plasma cotinine is a measure of daily nicotine exposure. Samples were measured in ng/mL. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
| Intervention | ng/mL (Mean) |
|---|---|
| Reduced Nicotine Content Cigarettes | 82.8 |
| Usual Nicotine Content Cigarettes | 259.0 |
A 16-item scale on depression symptoms. The scale range is 0-27 where 0 = Least Severe and 27 = Most Severe. (NCT01928758)
Timeframe: Measured at the end of the last 3 weeks of randomization trial phase
| Intervention | score on a scale (Mean) |
|---|---|
| Reduced Nicotine Content Cigarettes | 5.5 |
| Usual Nicotine Content Cigarettes | 5.3 |
3 trials available for carbon monoxide and Mood Disorders
| Article | Year |
|---|---|
A pilot randomized controlled trial of smartphone-assisted mindfulness-based intervention with contingency management for smokers with mood disorders.
Topics: Adult; Carbon Monoxide; Humans; Mindfulness; Mood Disorders; Pilot Projects; Smartphone; Smokers; Sm | 2022 |
Carbon monoxide feedback in a motivational decision support system for nicotine dependence among smokers with severe mental illnesses.
Topics: Adult; Behavior Therapy; Carbon Monoxide; Decision Support Techniques; Feedback; Female; Humans; Mal | 2013 |
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Me | 2017 |